Novo Nordisk sues Singapore biotech firm over $1.3 billion acquisition dispute
Novo Nordisk, the Danish pharmaceutical giant, has filed a lawsuit against Singapore-based KBP Biosciences and its founder, Huang Zhenhua, alleging KBP Biosciences misrepresented the effectiveness of an experimental hypertension drug, …
Novo Nordisk sues Singapore biotech firm over $1.3 billion acquisition dispute Read More